BC
Blackhill Capital Portfolio holdings
AUM
$1.73B
1-Year Return
14.57%
This Quarter Return
+3.91%
1 Year Return
+14.57%
3 Year Return
+150.13%
5 Year Return
+277.07%
10 Year Return
+454.51%
AUM
$896M
AUM Growth
+$33.1M
(+3.8%)
Cap. Flow
+$4.94M
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
86.92%
Holding
52
New
–
Increased
4
Reduced
7
Closed
–
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
+$6.36M |
| 2 |
Merck
MRK
|
+$904K |
| 3 |
AbbVie
ABBV
|
+$590K |
| 4 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$43.4K |
Top Sells
| 1 |
Zoetis
ZTS
|
+$1.66M |
| 2 |
Eli Lilly
LLY
|
+$515K |
| 3 |
Williams-Sonoma
WSM
|
+$471K |
| 4 |
Bristol-Myers Squibb
BMY
|
+$250K |
| 5 |
Zimmer Biomet
ZBH
|
+$25.8K |
Sector Composition
| 1 | Consumer Discretionary | 53.95% |
| 2 | Healthcare | 29.96% |
| 3 | Technology | 7.19% |
| 4 | Communication Services | 2.16% |
| 5 | Consumer Staples | 1.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Williams-Sonoma
WSM
$24B
| $480M | 53.61% |
7,894,994
-7,746
| -0.1% | -$471K |
|
|
2
Eli Lilly
LLY
$677B
| $50M | 5.58% |
145,633
-1,500
| -1% | -$515K |
|
3
Apple
AAPL
$3.47T
| $43.4M | 4.84% |
263,000
| – | – |
|
|
4
AbbVie
ABBV
$386B
| $42M | 4.68% |
263,260
+3,700
| +1% | +$590K |
|
|
5
Johnson & Johnson
JNJ
$429B
| $30.8M | 3.44% |
198,850
+41,020
| +26% | +$6.36M |
|
6
Abbott
ABT
$233B
| $30.5M | 3.4% |
301,230
| – | – |
|
|
7
Bristol-Myers Squibb
BMY
$94B
| $30.3M | 3.38% |
437,264
-3,600
| -0.8% | -$250K |
|
|
8
Zoetis
ZTS
$65.7B
| $26.7M | 2.99% |
160,714
-10,000
| -6% | -$1.66M |
|
|
9
Merck
MRK
$207B
| $23.9M | 2.67% |
225,100
+8,500
| +4% | +$904K |
|
10
Microsoft
MSFT
$3.79T
| $20.8M | 2.32% |
72,050
| – | – |
|
11
Walt Disney
DIS
$208B
| $15.7M | 1.75% |
156,300
| – | – |
|
12
Caterpillar
CAT
$202B
| $13.7M | 1.53% |
60,000
| – | – |
|
13
Pfizer
PFE
$136B
| $13.1M | 1.46% |
320,301
| – | – |
|
|
14
Zimmer Biomet
ZBH
$20.4B
| $10.7M | 1.2% |
82,950
-200
| -0.2% | -$25.8K |
|
15
Kimberly-Clark
KMB
$42.5B
| $9.53M | 1.06% |
71,000
| – | – |
|
16
Mastercard
MA
$525B
| $7.27M | 0.81% |
20,000
| – | – |
|
17
Berkshire Hathaway Class B
BRK.B
$1.07T
| $6.72M | 0.75% |
21,748
| – | – |
|
18
Procter & Gamble
PG
$370B
| $6.67M | 0.74% |
44,871
| – | – |
|
19
Cigna
CI
$80.8B
| $5.57M | 0.62% |
21,779
| – | – |
|
20
Enterprise Products Partners
EPD
$68.8B
| $2.82M | 0.31% |
108,704
-946
| -0.9% | -$24.5K |
|
|
21
Berkshire Hathaway Class A
BRK.A
$1.06T
| $2.79M | 0.31% |
6
| – | – |
|
|
MMP
22
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $2.15M | 0.24% |
39,600
+800
| +2% | +$43.4K |
|
23
Amazon
AMZN
$2.43T
| $2.08M | 0.23% |
20,100
| – | – |
|
24
Medtronic
MDT
$121B
| $1.95M | 0.22% |
24,177
| – | – |
|
25
Chevron
CVX
$317B
| $1.88M | 0.21% |
11,550
| – | – |
|